Related Experiment Video
Updated: Feb 17, 2026

Simultaneous Measurement of HDAC1 and HDAC6 Activity in HeLa Cells Using UHPLC-MS
Published on: August 10, 2017
Capsaicin-Inspired Hydroxamate Hybrids as Selective HDAC6 Inhibitors with Antiproliferative Activity in Hematological
Lara Gimenez Borges1, Thais Nascimento de Oliveira Alves1, Sandra Valeria Vassiliades1
1Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, São Paulo 05508-900, Brazil.
Abstract:
A series of capsaicin-inspired benzodioxol-benzyl-hydroxamate hybrids was synthesized in three steps with high purity (≥95%) and excellent yields (71-94%). Compounds 7a and 7c exhibited the strongest antiproliferative effects against Jurkat, Namalwa, and K-562 cells (IC50 = 3.0-4.5 μM). Enzymatic assays revealed potent and selective HDAC6 inhibition in the nanomolar range (IC5 0 = 0.040 μM ± 0.011 for 7a and 0.007 μM ± 0.001 for 7c), with over 300- and 1600-fold selectivity versus HDAC1, respectively. Western blot confirmed target engagement through α-tubulin hyperacetylation, while molecular docking and dynamics studies supported stable bidentate zinc coordination and favorable hydrophobic interactions in the HDAC6 active site. Computational ADMET analyses further supported the experimental findings. These findings identify 7a and 7c as potent and selective HDAC6 inhibitors with antiproliferative activity in hematologic tumor cells, highlighting benzodioxol-benzyl hydroxamate hybrids as promising scaffolds for anticancer drug development.
More Related Videos
09:11Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
11:06Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
Published on: September 20, 2017
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Inhibition of Cdk Activity